Dana joined the Rare Disease Translational Center in September 2024, where she manages a portfolio of rare disease projects that include, but is not limited to, neurodevelopmental and neurodegenerative disorders, muscular dystrophies, congenital disorders of glycosylation, and lysosomal storage disorders.
Dana received her B.S. in Biochemistry from Roanoke College in Virginia. She then studied the neuropathology underlying sensory dysfunction in a female mouse model of Rett Syndrome in the lab of Dr. Keerthi Krishnan at the University of Tennessee for her graduate work. She then moved to Children's Hospital of Philadelphia for a postdoctoral position in Dr. Elizabeth Bhoj's laboratory. Her postdoctoral work focused on the characterization of multiple mouse models of novel monogenic neurodevelopmental and neurodegenerative pediatric disorders.